What is Generate Biomedicines, Inc. 's total liabilities?

Generate Biomedicines, Inc. (GENB) reported total liabilities of $110.94M in Q1 2026.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Generate Biomedicines, Inc. GENB Total Liabilities

Total Liabilities at other companies

MYR GroupMYRG

$970.61M-0.3%

SSR MiningSSRM

$107.25M-35.9%

Piper SandlerPIPR

$572.2M+29.3%

RepligenRGEN

$825.31M-4.8%

NNN REITNNN

$5.03B+7.8%

American Healthcare REITAHR

$2.08B-3.8%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total liabilities?: Generate Biomedicines, Inc. (GENB) reported total liabilities of $110.94M in Q1 2026.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.